🇺🇸 FDA
Pipeline program

PL2200 fasted

PL-ASA-003

Phase 1 small_molecule completed

Quick answer

PL2200 fasted for Healthy is a Phase 1 program (small_molecule) at Protalix BioTherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Protalix BioTherapeutics
Indication
Healthy
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials